The DOI matches its Crossref record; 153 of the 157 references it cites were found in a registry or an index.
Antidepressants for the treatment of depression in people with cancer
Open accessAbstract
Antidepressants for the treatment of depression in people with cancer (Review)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence of enduring effects of conventional psycho-or pharmacotherapy is limited or ambiguous (Akechi et al., 2008;Ostuzzi et al., 2018).”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Ostuzzi et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Cochrane review concluded that the evidence for medications compared with placebo was of low certainty based on the limited number and low quality of studies.”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pharmacologic management was investigated in a 2018 Cochrane review of antidepressant use in cancer patients with MDD and no difference between antidepressants (as a class) and placebo on symptoms of depression at 6-12 weeks was found.57”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [57]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Also, head-to-head comparisons of selective serotonin reuptake inhibitors versus tricyclic antidepressants showed no difference.57”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [57]
The cited source says what the claim attributes to it.
In the citing paper
“a conclusion informed by the 2018 Cochrane review of null findings for antidepressant use for MDD in patients with cancer at 6-12 weeks, a sufficient interval in pharmacologic trials for effects to be detected.57”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [57]
The cited source says what the claim attributes to it.
In the citing paper
“es el tratamiento de elección en depresión por delante del tratamiento farmacológico, por la mala tolerabilidad e interacciones farmacológicas de los antidepresivos en estos pacientes (27 ,28) , porque se han encontrado resultados similares entre la medicación y el placebo en personas con cáncer (29) , y porque los pacientes, tanto oncológicos como no oncológicos, suelen preferirla a la medicación”
From AVANZACT: protocolo e intervención psicoterapéutica en cáncer avanzado basados en Terapia de Aceptación y Compromiso. (2025) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Psychotherapy for depression among incurable cancer patients
Akechi, T., Okuyama, T., Onishi, J., Morita, T., & Furukawa, T. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005537.pub2 · Cited by 198
RetractedDrugs versus placebo for dysthymia
de Lima, M. S., Moncrieff, J., & Soares, B. G. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001130 · Cited by 81
RetractedDrugs versus placebo for dysthymia
de Lima, M. S., Moncrieff, J., & Soares, B. G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001130.pub2 · Cited by 16
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
(1992) · PubMed · Cited by 33,716
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Flagged first, then by citations
4 of the 157 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Carmen, 1990, Amitriptilin as coanalgesic in cancerous patients, Salud Mental, 13, 1
- Hua, 2009, Investigation and intervening therapy to depression of malignant hematological diseases Baixuebing, Linbaliu, Baixuebing, Linbaliu [Journal of Leukaemia and Lymphoma], 18, 432
- Montgomery C (contact name) A randomized controlled trial of venlafaxine versus placebo for depression amongst persons with lymphoma or leukaemia International Standard Randomised Controlled Trial Number Register 2003 10.1186/ISRCTN51232664 · DOI
- Tondlová, 2002, Citalopram and dosulepine in adjuvant treatment of oncological pain, Bolest, 4
- Zhang, 2003, Paroxetine in treatment of cancer patients with anxiety and depression, Zhongguo zin li wei sheng za zhi (Chinese Mental Health Journal), 17, 482
- Zvukova, 2011, Pharmacological correction of psychoemotional states of patients with thyroid nodules in the preoperative period, Russian Journal of Medicine, 3c, 31
- American Psychiatric Association, 1980, Diagnostic and Statistical Manual of Mental Disorders (DSM-III)
- WHO, 1978, The Ninth Revision of the International Classification of Diseases and Related Health Problems (ICD-9)
- WHO, 1992, The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10)
Cited by
Sorted by citations
Items 101–158 of 158
Zinnah, K. M. A., Munna, A. N., Seol, J., & Park, S. (2025) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/jcpt/7538839 · Cited by 1
Real‐World Use, Effectiveness and Tolerability of Antidepressant Treatment in Oncology Patients
Simonetti, A., Grisoni, F., Restaino, A., Calderoni, C., Camardese, G., D’Onofrio, A. M., Koukopoulos, A. E., Montanari, S., Janiri, D., & Sani, G. (2025) · Psycho-Oncology · doi:10.1002/pon.70340 · Cited by 1
Khan, Z., Weaver, S., Dando, R. V., Schlag, A. K., Neill, J. C., & Wainwright, V. (2026) · Qualitative Health Research · doi:10.1177/10497323261419338 · Cited by 1
Rayner, R., Shaw, J., & Hunt, C. J. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02146-y · Cited by 2
Hirayama, T., Ogawa, Y., Ogawa, A., Igarashi, E., Soejima, S., Hata, K., Utsumi, Y., Mashiko, Y., Ogata, K., Kayano, A., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-10926-y · Cited by 1
Best, G., Morunga, E., Wells, A., Allison, J., & Reynolds, L. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2397427 · Cited by 1
Bires, J. L. (2025) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2025.2482917 · Cited by 1
Andersen, B. L., Conley, C. C., & Blevins, T. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00077-7 · Cited by 1
Boudin, G., Laviec, H. S., Ghewy, L., Bon, P. L., Lebaube, S., Machavoine, J., Denhaerynck, J., Morello, R., & Beauplet, B. (2022) · European Journal of Cancer Care · doi:10.1111/ecc.13591 · Cited by 1
Chronic Pain Syndrome in Patients with Cancer Pain: Controversial Use of Amitriptyline
Sa, L., Усова, Н. Н., & Литвинов, Г. Е. (2020) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2020.10.1.044 · Cited by 1
Journey To The Centre Of The Mind: Psychedelic Treatment of Mental Health in Aotearoa
Lutyens, D. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.21904854 · Cited by 2
Kapfhammer, H. (2023) · Springer eBooks · doi:10.1007/978-3-662-68309-5_5 · Cited by 1
Shirama, F. H. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2018.tde-28112017-163739 · Cited by 1
Ghoshal, A. (2020) · Indian Journal of Palliative Care · doi:10.4103/ijpc.ijpc_96_19
Psychoonkologie als Teil eines ganzheitlichen Behandlungskonzepts bei Krebs
Nahi, I., Roduner, A., Wagner-Huber, R., & Bayerlein, B. (2021) · Urologie in der Praxis · doi:10.1007/s41973-021-00163-w
Mechanism of chronic stress to promote tumor development and the intervention.
Liu, Y., Zeng, Y., Li, Y., Ke, J., Pan, Y., Liu, X., Peng, Y., & Wu, F. (2022) · PubMed Central · doi:10.11817/j.issn.1672-7347.2022.210589
Domingo Cristina, G., Pandy, J. G. P., & Francia, M. B. D. (2022) · Asian Pacific Journal of Cancer Care · doi:10.31557/apjcc.2022.7.4.695-700
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_12
Fujisawa, D., Akechi, T., & Uchitomi, Y. (2022) · doi:10.1093/med/9780197615935.003.0004
Bielecka, A., Machnik, G., Linnebacher, M., Linnebacher, C. S., & Obuchowicz, E. (2023) · Research Square · doi:10.21203/rs.3.rs-2782714/v1
Medicinal usage of cannabis and its impact on mental health among cancer patients and survivors
Hernandez-Ortega, N., Chen, Y., Islam, J. Y., Rodriguez, D. L., Camacho‐Rivera, M., & Vidot, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90036-2.00042-9
Palliative and Supportive Medicine in Gastrointestinal Oncology
Berninger, L. E., Tapper, C. X., Browner, I. S., & Smith, T. J. (2024) · doi:10.1002/9781119756422.ch27
Risk of suicide in patients with thyroid cancer: protocol for a systematic review and meta-analysis
Li, C., Zhang, M., Wang, Q., Jiang, K., & Ye, Y. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080210
Neta, M. A. L. P., da Nóbrega, D. L. S., Silva, E. C. L., Miranda, L. V. L. M., Dalbom, V. C., Silva, M. C. O. D., Santos, R. T. A., Carvalho, V. S., Carvalho, R. F. V., & Santos, G. S. B. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-4
CIRURGIA PARENDODÔNTICA, APICECTOMIA COM RETRO-CAVIDADE E RETRO-OBTURAÇÃO: RELATO DE CASO
Neta, M. A. L. P., de Oliveira, I. F. F., Miranda, L. V. L. M., Melo, B. F., Santos, R. T. A., Csasznik, A., Carvalho, V. S., Mesquita, A. M. V., Bispo, D. D., & Santos, G. S. B. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-2
A RELEVÂNCIA DA ODONTOLOGIA LEGAL E SUA EFICÁCIA PARA IDENTIFICAÇÃO DE CADÁVERES
Neta, M. A. L. P., da Nóbrega, D. L. S., Silva, E. C. L., Miranda, L. V. L. M., Tissot, D., Santana, K. C., Silva, M. C. O. D., Mesquita, A. M. V., Santos, R. T. A., Carvalho, V. S., et al. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-9
FRATURA DE LIMA NA ENDODONTIA: RETIRAR OU PRESERVAR? UMA REVISÃO DE LITERATURA
Neta, M. A. L. P., de Oliveira, I. F. F., Miranda, L. V. L. M., Santos, R. T. A., Carvalho, V. S., Csasznik, A., Mesquita, A. M. V., Pinheiro, P. H. D. G., Vale, C. E. S., & Santos, G. S. B. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-7
CIMENTOS BIOCERÂMICOS REPARADORES NA ENDODONTIA
Neta, M. A. L. P., de Oliveira, I. F. F., Miranda, L. V. L. M., Santos, R. T. A., Carvalho, V. S., Csasznik, A., Mesquita, A. M. V., Pinheiro, P. H. D. G., Passinho, J. P. L., & Santos, G. S. B. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-8
Neta, M. A. L. P., da Nóbrega, D. L. S., Miranda, L. V. L. M., Melo, B. F., Santos, R. T. A., Dalbom, V. C., Carvalho, V. S., Csasznik, A., Nogueira, S. M. T., & Santos, G. S. B. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-5
RECESSÃO GENGIVAL: DIAGNÓSTICO E TRATAMENTO
Neta, M. A. L. P., Costa, L. E. J., Lindoso, L. S., Lima, Y. A. R., Fonseca, I. A., Filho, M. J. S. D. N., & dos Santos, G. S. B. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-11
Saúde e suas novas perspectivas - Volume 5
de Freitas, S. A. A., & Gondim, R. C. D. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952
ASPECTOS DO TRANSTORNO DEPRESSIVO MAIOR EM PACIENTES ONCOLÓGICOS
Salgado, J. E. A., Moura, E. H., Andrade, I. L. X. C., Silva, R. L., Melo, S. M., Cantinho, K. M. C. R., da Silva, E. A., Júnior, J. D. J. C., Neto, J. D. S., & Dantas, A. T. D. A. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-3
TOXINA BOTULÍNICA COMO ALTERNATIVA NO TRATAMENTO DA PARALISIA DE BELL
Neta, M. A. L. P., Dalbom, V. C., Pereira, J. R. P., Lindoso, L. S., Alcântara, C. R., Fonseca, I. A., Filho, M. J. S. D. N., & Santos, G. S. B. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-12
O USO DO MICROAGULHAMENTO ASSOCIADO AOS FÁRMACOS PARA O TRATAMENTO DA FLACIDEZ CORPORAL
de Oliveira, A. M. L., Rocha, D. D. M. B., Carvalho, F. F., de Jesus, H. R. B., Fonseca, M. G., & Rocha, A. O. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-1
Farias, R. D. C. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-6
A IMPORTÂNCIA DA EDUCAÇÃO EM SAÚDE NA FISIOTERAPIA: PROMOVENDO A ADESÃO DO PACIENTE AO TRATAMENTO
Silveira, M. T. P., de Oliveira, Á. N., Lage, L. M., & Martins, É. S. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5365952.1-10
Breeksema, J. J. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.912040905
Schaller, A., Bourquin, G., Araujo, I. A., & Ljuslin, M. (2023) · Revue internationale de soins palliatifs · doi:10.3917/inka.242.0098
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4975-9
Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients
Suresh, V., Lakhani, J. D., & Balaraman, R. (2024) · Journal of Natural Remedies · doi:10.18311/jnr/2024/35676
Yuan, Y., Xia, L., Wu, X., Yang, H., & Dou, L. (2024) · International Journal of Genomics · doi:10.1155/2024/8390463
Grundlagen der Diagnostik und Therapie
(2024) · Elsevier eBooks · doi:10.1016/b978-3-437-22487-4.16001-0
(2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21835-4.00116-5
Sevimoğlu, T., & Çalışkaner, Z. O. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01808-0
Santos, M. D. O., Silva, J. W. S. D. A., da Silva, J. S. F., & Cabral, A. G. S. (2025) · Research Society and Development · doi:10.33448/rsd-v14i9.49477
Santhosh, S., Ahmed, A., Mishra, V., Ippar, P., Rathod, N., Sonone, S. S., Gautam, A., Sharma, T., & Sankhla, M. S. (2025) · Springer proceedings in earth and environmental sciences · doi:10.1007/978-3-031-93444-5_25
(2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21322-9.00027-8
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210532
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210812
Fujisawa, D., Yoshikawa, E., Fujimori, M., 幸子, 荒., Kobayakawa, M., Kurata, A., Kayano, A., Ichikura, K., Igarashi, Y., Otani, H., et al. (2025) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaf209
Mahanti, K., Saha, J., Mondal, P., Sarkar, D., Pramanik, A., Das, D., Mahato, M., & Bhattacharyya, S. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.103810 · Cited by 1
Hong, S., Du, Y.-Y., Wang, G.-B., Wang, S., Zheng, Y.-F., Wang, N., Situ, H., & Wang, Z.-Y. (2026) · World Journal of Psychiatry · doi:10.5498/wjp.v16.i4.115981
Dorval, M., Chang, S.-L., Farzin, H., Nguyen, O., Stephan, J.-F., Tapp, D., Deschamps, P., Joly, Y., Moureaux, F., Foxman, R., et al. (2026) · Cahiers francophones de soins palliatifs · doi:10.7202/1123841ar
Nie, L., Liu, M., Chen, Z., Luan, C., Liu, D., Chen, B., Wang, J., & Lei, C. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1741755
“A single-session duration of 40 minutes (Hedges ’ g= − 0.32; 95% CrI, − 0.44 to − 0.21) and a frequency of six sessions per week (Hedges ’ g= − 0.47; 95% CrI, − 0.64 to − 0.29) yielded optimal effects (Supplementary Material 12).”
InfluentialPerceived Social Support, Anxiety, and Depression Among Women With Breast Cancer
Dreidi, M. M., Asmar, I., & Ayayda, M. (2026) · ONCOLOGY · doi:10.46883/2026.25921070
Birling, Y., Bhuyan, D., Feng, F., Jia, M., Liu, J., Zhang, H., Rahimi, M., Yu, W.-Y., Carlson, L. E., Boge, H. B., et al. (2026) · Current Oncology Reports · doi:10.1007/s11912-026-01790-7
Chiang, Y., Yi, C.-H., Yin, C.-H., Couper, J., Chang, C., Pan, C., & Chen, J.-S. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10868-8
Tsang, V. W. L., Kryskow, P., Watler, C., Allard, P., & Dames, S. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1767215
Metadata
- Authors
- Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M.
- Affiliations
- University of Verona (IT)
- King's College London (GB)
- Institut Gustave Roussy (FR)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-04-23
- Volume
- 2018
- Issue
- 4
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2940589604
- Cited by
- 158
- References
- 157
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 44 · 2023: 21 · 2022: 29 · 2021: 18 · 2020: 8 · 2019: 9 · 2018: 2
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Update notices
- new_version (2023-03-31)
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0515-10102)
- King's College London
- Evidence Synthesis Programme
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressants, depression, cancer, cancer-related depression, antidepressant efficacy, antidepressant safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
